The benefits and harms of drug treatment for type 2 diabetes
In light of the failure of intensive glycaemic control to provide substantial risk reduction in cardiovascular and kidney disease, researchers have increasingly shifted away from a glucose-centric paradigm. This study found that compared with standard treatments, adding finerenone (inhibits the effects...
Read more